COVID-19 Vaccine Shipped, and Drug Trials Start
By News
Published 4 years ago on
February 27, 2020
Share
[aggregation-styles]
TIME
Moderna Therapeutics, a biotech company based in Cambridge, Mass., has shipped the first batches of its COVID-19 vaccine. The vaccine was created just 42 days after the genetic sequence of the COVID-19 virus, called SARS-CoV-2, was released by Chinese researchers in mid-January.
The first vials were sent to the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) in Bethesda, MD, which will ready the vaccine for human testing as early as April.
NIH scientists also began testing an antiviral drug called remdesivir that had been developed for Ebola, on a patient infected with SARS-CoV-2. The trial is the first to test a drug for treating COVID-19, and will be led by a team at the University of Nebraska Medical Center.
The first patient to volunteer for the ground-breaking study is a passenger who was brought back to the US after testing positive for the disease aboard the Diamond Princess. Others diagnosed with COVID-19 who have been hospitalized will also be part of the study.
Remdesivir showed encouraging results among animals infected with two related coronaviruses, one responsible for severe acute respiratory syndrome (SARS) and another for causing Middle East respiratory syndrome (MERS).
Read More →
TIME
Moderna Therapeutics, a biotech company based in Cambridge, Mass., has shipped the first batches of its COVID-19 vaccine. The vaccine was created just 42 days after the genetic sequence of the COVID-19 virus, called SARS-CoV-2, was released by Chinese researchers in mid-January.
The first vials were sent to the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) in Bethesda, MD, which will ready the vaccine for human testing as early as April.
NIH scientists also began testing an antiviral drug called remdesivir that had been developed for Ebola, on a patient infected with SARS-CoV-2. The trial is the first to test a drug for treating COVID-19, and will be led by a team at the University of Nebraska Medical Center.
The first patient to volunteer for the ground-breaking study is a passenger who was brought back to the US after testing positive for the disease aboard the Diamond Princess. Others diagnosed with COVID-19 who have been hospitalized will also be part of the study.
Remdesivir showed encouraging results among animals infected with two related coronaviruses, one responsible for severe acute respiratory syndrome (SARS) and another for causing Middle East respiratory syndrome (MERS).
Read More →
By Alice Park | 25 Feb 2020
RELATED TOPICS:
Unlocking the Secrets to Fresno State’s Superb Baseball Season
Sports /
11 hours ago
Get a 3D First Look at Merced’s High-Speed Rail Station Design
Events /
13 hours ago
California Court to Decide on Transgender Ballot Measure Wording
Politics /
13 hours ago
Rare House Vote Sees Ukraine, Israel Aid Advance as Democrats Join Republicans
Politics /
15 hours ago
Full Jury and 6 Alternates Seated in Trump’s Hush Money Trial
Crime /
15 hours ago
Man Sets Himself on Fire Outside Trump Hush Money Trial Court
NEW YORK — Police officials said they were reviewing whether to restrict access to a public park outside the courthouse where former Preside...
U.S. /
9 hours ago
Categories
Latest
Videos
U.S. /
9 hours ago
Man Sets Himself on Fire Outside Trump Hush Money Trial Court
Economy /
10 hours ago
Real Estate Experts Talk Fresno’s Economic Future. Are Tough Times Ahead?
Sports /
11 hours ago
Unlocking the Secrets to Fresno State’s Superb Baseball Season
Events /
13 hours ago
Get a 3D First Look at Merced’s High-Speed Rail Station Design
Politics /
13 hours ago
California Court to Decide on Transgender Ballot Measure Wording
Economy /
1 day ago